Topics

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

20:18 EST 12 Feb 2020 | Xconomy

The RAS family of proteins are one of the hottest targets in cancer research despite being one of the hardest for drug hunters to hit. Revolution Medicines has raised $238 million in an IPO to finance development of therapies that it says can drug these molecules in a novel way. On Wednesday evening, Revolution priced […]

Original Article: Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

NEXT ARTICLE

More From BioPortfolio on "Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...